Bahl & Gaynor’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-10,446
Closed -$371K 398
2016
Q2
$371K Buy
10,446
+585
+6% +$22.8K ﹤0.01% 339
2016
Q1
$386K Buy
9,861
+87
+0.9% +$3.25K 0.01% 337
2015
Q4
$420K Buy
9,774
+229
+2% +$10.1K 0.01% 333
2015
Q3
$401K Buy
9,545
+220
+2% +$10.3K 0.01% 343
2015
Q2
$465K Buy
9,325
+803
+9% +$38K 0.01% 331
2015
Q1
$384K Buy
8,522
+924
+12% +$41.5K 0.01% 336
2014
Q4
$366K Buy
7,598
+1,959
+35% +$93.1K 0.01% 335
2014
Q3
$270K Buy
+5,639
New +$274K ﹤0.01% 375

Other funds holding MET

Bahl & Gaynor's MET Position: Q3 2016 in Review

Bahl & Gaynor sold out of MetLife (MET) in Q3 2016, closing a stake of 10,446 shares — an estimated $371K sold.

Bahl & Gaynor first reported a position in MET in Q3 2014 and held it in 8 quarters. The position peaked at $465K in Q2 2015. 962 funds tracked by Wall St. Rank hold MET as of Q3 2016.

  • Bahl & Gaynor reported no remaining MetLife position as of Q3 2016 after selling out during the quarter.
  • Bahl & Gaynor sold 10,446 MetLife shares in Q3 2016, an estimated $371K.
  • Bahl & Gaynor first reported a position in MetLife in Q3 2014 and held it in 8 quarters.
  • Bahl & Gaynor's MetLife position peaked at $465K in Q2 2015.
  • 962 funds tracked by Wall St. Rank held MetLife as of Q3 2016.

Based on Bahl & Gaynor's 13F filing for Q3 2016, filed 7 Nov 2016.